A detailed history of Granite Group Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Granite Group Advisors, LLC holds 389 shares of LLY stock, worth $293,695. This represents 0.22% of its overall portfolio holdings.

Number of Shares
389
Previous 389 -0.0%
Holding current value
$293,695
Previous $352 Million 2.15%
% of portfolio
0.22%
Previous 0.27%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$724.87 - $909.04 $288,498 - $361,797
-398 Reduced 50.57%
389 $352 Million
Q4 2023

Apr 03, 2024

BUY
$525.19 - $619.13 $413,324 - $487,255
787 New
787 $578 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $717B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Granite Group Advisors, LLC Portfolio

Follow Granite Group Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Group Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Group Advisors, LLC with notifications on news.